Author:
Tagliabue Elda,Campiglio Manuela,Pupa Serenella M.,Ménard Sylvie,Balsari Andrea
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference65 articles.
1. Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer;Spector;J Clin Oncol,2009
2. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt is required for antibody-mediated effects on p27, cyclin D1, and antitumor action;Yakes;Cancer Res,2002
3. Trastuzumab (herceptin), a humanized anti-HER2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells;Molina;Cancer Res,2001
4. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets;Clynes;Nat Med,2000
5. Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents;Boone;Mol Cancer Ther,2009
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献